{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:06:21Z","timestamp":1777032381722,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-023-00732-w","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T01:02:07Z","timestamp":1693616527000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adult-onset Alexander disease among patients of Jewish Syrian descent"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6448-4505","authenticated-orcid":false,"given":"Saar","family":"Anis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsvia","family":"Fay-Karmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lassman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Shbat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orit","family":"Lesman-Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nofar","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ortal","family":"Barel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Dominissini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odelia","family":"Chorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elon","family":"Pras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lior","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Hassin-Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"key":"732_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/83679","volume":"27","author":"M Brenner","year":"2001","unstructured":"Brenner M, Johnson AB, Boespflug-Tanguy O et al (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27:117\u2013120. https:\/\/doi.org\/10.1038\/83679","journal-title":"Nat Genet"},{"key":"732_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1212\/wnl.26.7.607","volume":"26","author":"LS Russo","year":"1976","unstructured":"Russo LS, Aron A, Anderson PJ (1976) Alexander\u2019s disease: a report and reappraisal. Neurology 26:607\u2013614. https:\/\/doi.org\/10.1212\/wnl.26.7.607","journal-title":"Neurology"},{"key":"732_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/088307389300800205","volume":"8","author":"CL Pridmore","year":"1993","unstructured":"Pridmore CL, Baraitser M, Harding B et al (1993) Alexander\u2019s disease: clues to diagnosis. J Child Neurol 8:134\u2013144. https:\/\/doi.org\/10.1177\/088307389300800205","journal-title":"J Child Neurol"},{"key":"732_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-2000-7479","volume":"31","author":"S Springer","year":"2000","unstructured":"Springer S, Erlewein R, Naegele T et al (2000) Alexander disease\u2013classification revisited and isolation of a neonatal form. Neuropediatrics 31:86\u201392. https:\/\/doi.org\/10.1055\/s-2000-7479","journal-title":"Neuropediatrics"},{"key":"732_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1212\/WNL.0b013e3182309f72","volume":"77","author":"M Prust","year":"2011","unstructured":"Prust M, Wang J, Morizono H et al (2011) GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology 77:1287\u20131294. https:\/\/doi.org\/10.1212\/WNL.0b013e3182309f72","journal-title":"Neurology"},{"key":"732_CR6","unstructured":"Srivastava S, Waldman A, Naidu S (1993) Alexander Disease. In: Adam MP, Everman DB, Mirzaa GM et al (eds) GeneReviews\u00ae. University of Washington, Seattle, Seattle (WA)"},{"key":"732_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1212\/01.wnl.0000200905.43191.4d","volume":"66","author":"AJ Barkovich","year":"2006","unstructured":"Barkovich AJ, Messing A (2006) Alexander disease: not just a leukodystrophy anymore. Neurology 66:468\u2013469. https:\/\/doi.org\/10.1212\/01.wnl.0000200905.43191.4d","journal-title":"Neurology"},{"key":"732_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1399-0004.2007.00869.x","volume":"72","author":"F Caroli","year":"2007","unstructured":"Caroli F, Biancheri R, Seri M et al (2007) GFAP mutations and polymorphisms in 13 unrelated Italian patients affected by Alexander disease. Clin Genet 72:427\u2013433. https:\/\/doi.org\/10.1111\/j.1399-0004.2007.00869.x","journal-title":"Clin Genet"},{"key":"732_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1212\/01.wnl.0000438230.33223.bc","volume":"82","author":"J Graff-Radford","year":"2014","unstructured":"Graff-Radford J, Schwartz K, Gavrilova RH et al (2014) Neuroimaging and clinical features in type II (late-onset) Alexander disease. Neurology 82:49\u201356. https:\/\/doi.org\/10.1212\/01.wnl.0000438230.33223.bc","journal-title":"Neurology"},{"key":"732_CR10","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3174\/ajnr.A1060","volume":"29","author":"L Farina","year":"2008","unstructured":"Farina L, Pareyson D, Minati L et al (2008) Can MR imaging diagnose adult-onset Alexander disease? AJNR Am J Neuroradiol 29:1190\u20131196. https:\/\/doi.org\/10.3174\/ajnr.A1060","journal-title":"AJNR Am J Neuroradiol"},{"key":"732_CR11","doi-asserted-by":"publisher","unstructured":"Messing A (2018) Alexander disease. In: Handbook of Clinical Neurology. Elsevier, pp 693\u2013700. https:\/\/doi.org\/10.1016\/B978-0-444-64076-5.00044-2","DOI":"10.1016\/B978-0-444-64076-5.00044-2"},{"key":"732_CR12","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1523\/JNEUROSCI.5384-11.2012","volume":"32","author":"A Messing","year":"2012","unstructured":"Messing A, Brenner M, Feany MB et al (2012) Alexander disease. J Neurosci 32:5017\u20135023. https:\/\/doi.org\/10.1523\/JNEUROSCI.5384-11.2012","journal-title":"J Neurosci"},{"key":"732_CR13","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1007\/s00415-011-6056-3","volume":"258","author":"T Yoshida","year":"2011","unstructured":"Yoshida T, Sasaki M, Yoshida M et al (2011) Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neurol 258:1998\u20132008. https:\/\/doi.org\/10.1007\/s00415-011-6056-3","journal-title":"J Neurol"},{"key":"732_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ejpn.2014.03.009","volume":"18","author":"D Nishri","year":"2014","unstructured":"Nishri D, Edvardson S, Lev D et al (2014) Diagnosis by whole exome sequencing of atypical infantile onset Alexander disease masquerading as a mitochondrial disorder. Eur J Paediatr Neurol 18:495\u2013501. https:\/\/doi.org\/10.1016\/j.ejpn.2014.03.009","journal-title":"Eur J Paediatr Neurol"},{"key":"732_CR15","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fneur.2019.01124","volume":"10","author":"A Ciammola","year":"2019","unstructured":"Ciammola A, Sangalli D, Sassone J et al (2019) A novel mutation of GFAP causing adult-onset Alexander disease. Front Neurol 10:1124. https:\/\/doi.org\/10.3389\/fneur.2019.01124","journal-title":"Front Neurol"},{"key":"732_CR16","doi-asserted-by":"publisher","unstructured":"Hayashi Y, Nagasawa M, Asano T et al (2017) Central hypothermia associated with Alexander disease. A case report. Clin Neurol Neurosurg 157:31\u201333. https:\/\/doi.org\/10.1016\/j.clineuro.2017.03.013","DOI":"10.1016\/j.clineuro.2017.03.013"},{"key":"732_CR17","doi-asserted-by":"publisher","unstructured":"Sreedharan J, Shaw CE, Jarosz J, Samuel M (2007) Alexander disease with hypothermia, microcoria, and psychiatric and endocrine disturbances. Neurology 68:1322\u20131323. https:\/\/doi.org\/10.1212\/01.wnl.0000259543.95222.9d","DOI":"10.1212\/01.wnl.0000259543.95222.9d"},{"key":"732_CR18","doi-asserted-by":"publisher","unstructured":"Kim B, Kim S, Jin MS (2018) Crystal structure of the human glial fibrillary acidic protein 1B domain. Biochem Biophys Res Commun 503:2899\u20132905. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.066","DOI":"10.1016\/j.bbrc.2018.08.066"},{"key":"732_CR19","doi-asserted-by":"publisher","unstructured":"Flint D, Li R, Webster LS et al (2012) Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. Hum Mutat 33:1141\u20131148. https:\/\/doi.org\/10.1002\/humu.22094","DOI":"10.1002\/humu.22094"},{"key":"732_CR20","doi-asserted-by":"publisher","unstructured":"Hsiao VC, Tian R, Long H et al (2005) Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J Cell Sci 118:2057\u20132065. https:\/\/doi.org\/10.1242\/jcs.02339","DOI":"10.1242\/jcs.02339"},{"key":"732_CR21","doi-asserted-by":"publisher","unstructured":"Der Perng M, Su M, Wen SF et al (2006) The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27. Am J Hum Genet 79:197\u2013213. https:\/\/doi.org\/10.1086\/504411","DOI":"10.1086\/504411"},{"key":"732_CR22","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1212\/wnl.58.10.1494","volume":"58","author":"JR Gorospe","year":"2002","unstructured":"Gorospe JR, Naidu S, Johnson AB et al (2002) Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology 58:1494\u20131500. https:\/\/doi.org\/10.1212\/wnl.58.10.1494","journal-title":"Neurology"},{"key":"732_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ana.20406","volume":"57","author":"R Li","year":"2005","unstructured":"Li R, Johnson AB, Salomons G et al (2005) Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 57:310\u2013326. https:\/\/doi.org\/10.1002\/ana.20406","journal-title":"Ann Neurol"},{"key":"732_CR24","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/archneur.60.9.1307","volume":"60","author":"E Stumpf","year":"2003","unstructured":"Balbi P, Salvini S, Fundar\u00f2 C, et al (2010) The clinical spectrum of late-onset Alexander disease: a systematic literature review. J Neurol 257:1955\u20131962. https:\/\/doi.org\/10.1007\/s00415-010-5706-1","journal-title":"Arch Neurol"},{"key":"732_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/jhg.2013.83","volume":"58","author":"T Yoshida","year":"2013","unstructured":"Brenner M (2014) Alexander\u2019s Disease. In: Aminoff MJ, Daroff RB (eds) Encyclopedia of the Neurological Sciences, 2nd Edn. Academic Press, Oxford, pp 106\u2013109","journal-title":"J Hum Genet"},{"key":"732_CR26","doi-asserted-by":"publisher","unstructured":"Stumpf E, Masson H, Duquette A et al (2003) Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene. Arch Neurol 60:1307\u20131312. https:\/\/doi.org\/10.1001\/archneur.60.9.1307","DOI":"10.1001\/archneur.60.9.1307"},{"key":"732_CR27","doi-asserted-by":"publisher","unstructured":"Yoshida T, Mizuta I, Saito K et al (2013) Effects of a polymorphism in the GFAP promoter on the age of onset and ambulatory disability in late-onset Alexander disease. J Hum Genet 58:635\u2013638. https:\/\/doi.org\/10.1038\/jhg.2013.83","DOI":"10.1038\/jhg.2013.83"},{"key":"732_CR28","doi-asserted-by":"publisher","unstructured":"Hagemann TL, Powers B, Mazur C, et al (2018) Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease: GFAP ASO Therapy in AxD. Ann Neurol 83:27\u201339. https:\/\/doi.org\/10.1002\/ana.25118","DOI":"10.1002\/ana.25118"},{"key":"732_CR29","doi-asserted-by":"publisher","unstructured":"Hagemann TL, Powers B, Lin N-H et al (2021) Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment. Sci Transl Med 13:eabg4711. https:\/\/doi.org\/10.1126\/scitranslmed.abg4711","DOI":"10.1126\/scitranslmed.abg4711"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-023-00732-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-023-00732-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-023-00732-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T10:07:13Z","timestamp":1696241233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-023-00732-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1007\/s10048-023-00732-w","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"18 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study, and if deceased\u2014from their legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}